Find us on Social Media:

Oligomeric Proanthocyanidins (OPCs)
What is it? Overview Usage Side Effects and Warnings
Answers
askAsk

Oligomeric Proanthocyanidins (OPCs) Usage

Written by FoundHealth.

Therapeutic Uses

The best-documented use of OPCs is to treat chronic venous insufficiency , a condition closely related to varicose veins. In both of these conditions, blood pools in the legs, causing aching, pain, heaviness, swelling, fatigue, and unsightly visible veins. Fairly good preliminary evidence suggests that OPCs from pine bark or grape seed can relieve the leg pain and swelling of chronic venous insufficiency. 1 2 3 4 However, no studies have evaluated whether regular use of OPCs can make visible varicose veins disappear, or prevent new ones from developing.

Other small, double-blind trials suggest that OPCs may help reduce swelling caused by injuries or surgery . 5 6 Evidence from one small, double-blind trial suggests that OPCs from bilberry and grape seed may reduce the general fluid retention and swelling that can occur in premenstural syndrome (PMS) . 7 One large study found some evidence that use of OPCs from pine bark might help prevent the leg blood clots that can develop on a long airplane flight. 8 Two preliminary studies found evidence that OPCs from pine bark, alone or with arginine , may be helpful for impotence . 9 In a double-bind, placebo-controlled study of 61 children with attention deficit hyperactivity disorder (ADHD) , use of OPCs from pine bark (at a dose of 1 g per kg per day) appeared to improve some measurements of disease severity. 10 Two small, double-blind pilot studies suggest that OPCs from pine bark might help reduce asthma symptoms. 11 OPCs are also often recommended for allergies , but an 8-week, double-blind trial of 49 individuals found no benefit with grape seed extract. 12 OPCs might marginally improve blood sugar control in people with diabetes, according to a double-blind study of 77 people with type 2 diabetes. 13 Some evidence suggests that OPCs protect and strengthen collagen and elastin. 14 15 16 17 18 Theoretically, this could mean that OPCs are helpful for aging skin , and they are widely sold for this purpose, but there is as yet no direct evidence that the herbs work.

On the basis of their use in the treatment of varicose veins, OPCs are often recommended as a treatment for hemorrhoids as well, but there is no direct evidence to support this use. (Hemorrhoids are varicose veins in and around the anus.)

One study suggests that while OPCs alone may not reduce levels of cholesterol , some benefits may occur when taken in combination with chromium. 19 OPCs are strong antioxidants. Vitamin E defends against fat-soluble oxidants, and vitamin C neutralizes water-soluble ones, but OPCs are active against both types. 20 21 Based on the (unproven) belief that antioxidants offer many health benefits, regular use of OPCs has been proposed as a measure to prevent cancer , diabetic neuropathy and diabetic retinopathy , 22 and heart disease . 23 24 25 OPCs have been tried as a treatment for impaired night vision , 26 lupus (systemic lupus erythematosus), 27 easy bruising , 28 high blood pressure , 29 and liver cirrhosis . 30 However, more research needs to be performed to discover whether it actually provides any benefits in these conditions.

A double-blind, placebo-controlled study of questionable validity reported that use of OPCs from pine bark produced benefits in allsymptoms of menopause . 31 One study failed to find OPCs significantly helpful for weight loss . 32 Another failed to find OPCs helpful for reducing the side effects of radiation therapy for breast cancer. 33

References

  1. Thebaut JF, Thebaut P, Vin F. Study of Endotelon ? in functional manifestations of peripheral venous insufficiency [translated from French]. Gaz Med. 1985;92:96-100.
  2. Henriet JP. Exemplary study for a phlebotropic substance, the EIVE Study [translated from French]. Fairfield, CT: Primary Source; not dated.
  3. Delacroix P. Double-blind study of Endotelon ? in chronic venous insufficiency [translated from French]. La Revue de Medecine. 1981;27-28:1793-1802.
  4. Arcangeli P. Pycnogenol in chronic venous insufficiency. Fitoterapia. 71(3):236-44.
  5. Pecking A, Desprez-Curely JP, Megret G. Oligomeric grape flavanols (Endotelon) in the treatment of secondary upper limb lymphedemas [translated from French]. Study on file with manufacturer, International Nutrition Company (INC),Vaduz, Liechtenstein. 1989;69-73.
  6. Baruch J. Effect of Endotelon in postoperative edema. Results of a double-blind study versus placebo in 32 female patients [translated from French]. Ann Chir Plast Esthet. 1984;29:393-395.
  7. Christie S, Walker AF, Hicks SM, Abeyasekera S. Flavonoid supplement improves leg health and reduces fluid retention in pre-menopausal women in a double-blind, placebo-controlled study. Phytomedicine. 11(1):11-7.
  8. Belcaro G, Cesarone MR, Rohdewald P, et al. Prevention of venous thrombosis and thrombophlebitis in long-haul flights with Pycnogenol®. Clin Appl Thromb Hemost. 2004;10:373-377.
  9. Stanislavov R, Nikolova V. Treatment of erectile dysfunction with pycnogenol and L-arginine. J Sex Marital Ther. 29(3):207-13.
  10. Trebaticka J, Kopasova S, Hradecna Z, et al. Treatment of ADHD with French maritime pine bark extract, Pycnogenol®. Eur Child Adolesc Psychiatry. 2006 May 13. [Epub ahead of print]
  11. Hosseini S, Pishnamazi S, Sadrzadeh SM, Farid F, Farid R, Watson RR. Pycnogenol((R)) in the Management of Asthma. J Med Food. 4(4):201-209.
  12. Bernstein CK, Deng C, Shuklah R, et al. Double blind, placebo controlled (DBPC) study of grapeseed extract in the treatment of seasonal allergic rhinitis (SAR) [abstract]. J Allergy Clin Immunol. 2001;107:1018.
  13. Liu X, Wei J, Tan F, et al. Antidiabetic effect of Pycnogenol® French maritime pine bark extract in patients with diabetes type II. Life Sci. 2004;75:2505-2513.
  14. Maffei Facino R, Carini M, Aldini G, et al. Free radical scavenging action and anti-enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung. 1994;44:592-601.
  15. Kuttan R, Donnelly PV, Di Ferrante N. Collagen treated with (+)-catechin becomes resistant to the action of mammalian collagenase. Experientia. 37(3):221-3.
  16. Masquelier J. Procyanidolic oligomers. Parfums Cosmetiques Aromes. 1990;95:89-97.
  17. Masquelier J, Dumon MC, Dumas J. Stabilization of collagen by procyanidolic oligomers [in French; English abstract]. Acta Ther. 1981;7:101-105.
  18. Schwitters B, Masquelier J. OPC in Practice: Bioflavanols and their Applications. Rome, Italy: Alfa Omega; 1993.
  19. Preuss HG, Wallerstedt D, Talpur N, Tutuncuoglu SO, Echard B, Myers A, Bui M, Bagchi D. Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J Med. 31(5-6):227-46.
  20. Maffei Facino R, Carini M, Aldini G, et al. Free radical scavenging action and anti-enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung. 1994;44:592-601.
  21. Kuttan R, Donnelly PV, Di Ferrante N. Collagen treated with (+)-catechin becomes resistant to the action of mammalian collagenase. Experientia. 37(3):221-3.
  22. Schönlau F, Rohdewald P. Pycnogenol for diabetic retinopathy. A review. Int Ophthalmol. 24(3):161-71.
  23. Schwitters B, Masquelier J. OPC in Practice: Bioflavanols and their Applications. Rome, Italy: Alfa Omega; 1993.
  24. Wegrowski J, Robert AM, Moczar M. The effect of procyanidolic oligomers on the composition of normal and hypercholesterolemic rabbit aortas. Biochem Pharmacol. 33(21):3491-7.
  25. Uchida S, Edamatsu R, Hiramatsu M. Condensed tannins scavenge active oxygen free radicals. Med Sci Res. 1987;15:831-832.
  26. Corbe C, Boissin JP, Siou A. Light vision and chorioretinal circulation. Study of the effect of procyanidolic oligomers [translated from French]. J Fr Ophtalmol. 1988;11:453-460.
  27. Stefanescu M, Matache C, Onu A, Tanaseanu S, Dragomir C, Constantinescu I, Schönlau F, Rohdewald P, Szegli G. Pycnogenol efficacy in the treatment of systemic lupus erythematosus patients. Phytother Res. 15(8):698-704.
  28. Maffei Facino R, Carini M, Aldini G, et al. Free radical scavenging action and anti-enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung. 1994;44:592-601.
  29. Hosseini S, et al. A randomized, double-blind, placebo-controlled, prospective, 16 week crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patients. Nutr Res. 2001; 21:1251-1260.
  30. Lesbre FX. Effect of endotelon on the capillary fragility index in a specific group: cirrhotic subjects. Gaz Med Fr. 1983;90:332-337.
  31. Yang HM, Liao MF, Zhu SY, et al. A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol® on the climacteric syndrome in peri-menopausal women. Acta Obstet Gynecol Scand. 2007;86:978-985.
  32. Vogels N, Nijs IM, Westerterp-Plantenga MS. The effect of grape-seed extract on 24 h energy intake in humans. Eur J Clin Nutr. 58(4):667-73.
  33. Brooker S, Martin S, Pearson A, Bagchi D, Earl J, Gothard L, Hall E, Porter L, Yarnold J. Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration. Radiother Oncol. 79(1):45-51.
 
Share

0 Comments

No one has made any comments yet. Be the first!

Your Comment